Wells Fargo upgrades Ecolab to Overweight from Equal-Weight, raises price target to $380 from $315

Wells Fargo upgraded Ecolab to Overweight, raising its price target to $380 from $315, implying 24.8% upside from the Nov 12 close. Recent analyst targets range from $310 to $357.

Original reporting
Published Nov 13, 2026, 12:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wells Fargo upgrades Ecolab to Overweight from Equal-Weight, raises price target to $380 from $315 — source image
Decision brief

The 30-second read

$ECLBullishHigh
01

Why it matters

The upgrade could trigger short‑term buying, especially from momentum traders tracking analyst actions.

02

Market read

Ecolab's stock may experience a near‑term rally as the market incorporates the new target price.

03

What to watch

Potential cost pressures from raw‑material price volatility are not addressed.

Relevance 7/10Novelty 8/10Timing: today

Background

Wells Fargo's research note reflects a revised outlook for Ecolab based on recent performance and market conditions.

Company-level read

Ticker impact

$ECLBullishHigh confidence
Context

Wells Fargo upgraded Ecolab to Overweight and raised its price target to $380 from $315.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The upgrade and 20.6% price‑target increase signal improved outlook, prompting buying interest.

Market effects

May lift other industrial chemicals peers as analysts reassess sector valuation.

US chemical sector could see modest gains in the near term.

Limited to investors tracking US‑listed chemical companies.

Counterpoint

Some investors may view the target raise as overly optimistic given macro‑uncertainty.

Key entities

  • Wells Fargo

    Equity research firm issuing the upgrade.

  • Ecolab

    Provider of water, hygiene and infection control solutions.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.